Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis

Yan Sun1, Guanghui Wan1, Liping Liang1

  • 1Zaozhuang Traditional Chinese Medicine Hospital, Zaozhuang, Shandong, P.R. China.

Plos One
|April 8, 2020
PubMed

Insights

Taurolidine lock solutions significantly reduce catheter-related bloodstream infections (CRBSIs) in pediatric patients. Further high-quality trials are needed to confirm these findings for central venous catheter (CVC) use.

Area of Science:

  • Pediatric Infectious Diseases
  • Medical Device Infections
  • Pharmacological Interventions

Background:

  • Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in pediatric patients with central venous catheters (CVCs).
  • Taurolidine lock solutions are utilized to mitigate CRBSIs in both adult and pediatric populations.

Purpose of the Study:

  • To systematically evaluate the efficacy of taurolidine lock solutions in preventing CRBSIs in pediatric patients through a meta-analysis.
  • To determine the impact of taurolidine on CRBSI incidence and catheter removal rates in children.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (PubMed, EMBASE, Cochrane Library, etc.) up to November 1, 2019.
  • Included studies were randomized controlled trials (RCTs) comparing taurolidine lock solutions with control for CRBSI prevention in pediatric patients.
  • Meta-analysis was performed on data from four eligible RCTs.

Main Results:

  • Taurolidine significantly reduced the total number of CRBSIs compared to control (RR: 0.23; 95% CI: 0.13, 0.40).
  • A statistically significant reduction in CRBSI incidence (events per 1000 catheter days) was observed with taurolidine (MD: -1.12; 95% CI: -1.54, -0.71).
  • No significant difference was found in the number of catheters removed due to infection between taurolidine and control groups (RR: 0.68; 95% CI: 0.22, 2.10).

Conclusions:

  • Taurolidine lock solutions show potential in significantly reducing CRBSIs in pediatric patients using central venous catheters.
  • The current evidence base is limited by the quality of the included studies.
  • Further large-scale, high-quality randomized controlled trials are necessary to validate these findings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
150
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
190
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
217